Page last updated: 2024-09-03

pyroglutamyl-glutamyl-proline amide and thyroxine

pyroglutamyl-glutamyl-proline amide has been researched along with thyroxine in 1 studies

Compound Research Comparison

Studies
(pyroglutamyl-glutamyl-proline amide)
Trials
(pyroglutamyl-glutamyl-proline amide)
Recent Studies (post-2010)
(pyroglutamyl-glutamyl-proline amide)
Studies
(thyroxine)
Trials
(thyroxine)
Recent Studies (post-2010) (thyroxine)
620038,9891,4106,550

Protein Interaction Comparison

ProteinTaxonomypyroglutamyl-glutamyl-proline amide (IC50)thyroxine (IC50)
TransthyretinHomo sapiens (human)2.1939
UDP-glucuronosyltransferase 1A1 Homo sapiens (human)5.25
Solute carrier organic anion transporter family member 4C1Homo sapiens (human)8
Bile acid receptorHomo sapiens (human)7.86

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cremades, A; Del Rio-Garcia, J; PeƱafiel, R; Rausell, V; Smyth, DG1

Other Studies

1 other study(ies) available for pyroglutamyl-glutamyl-proline amide and thyroxine

ArticleYear
The thyrotropin-releasing hormone-like peptides pGlu-Phe-Pro amide and pGlu-Glu-Pro amide increase plasma triiodothyronine levels in the mouse; the activity is sensitive to testosterone.
    European journal of pharmacology, 1998, Sep-25, Volume: 358, Issue:1

    Topics: Animals; Antineoplastic Agents, Hormonal; Castration; Female; Male; Mice; Oligopeptides; Pyrrolidonecarboxylic Acid; Testosterone; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine

1998